Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study - Concepedia

Concepedia

Publication | Closed Access

Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study

335

Citations

19

References

2002

Year

W. Jonat, M. Kaufmann, Willi Sauerbrei, R.W. Blamey, J. Cuzick, M. Namer, I. Fogelman, J C de Haes, A. De Matteis, Alan L. Stewart,

Journal of Clinical Oncology

Abstract

Goserelin offers an effective, well-tolerated alternative to CMF in premenopausal patients with ER-positive and node-positive early breast cancer.

References

	Year	Citations

Page 1